Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ginkgo diterpene lactone meglumine injection on platelet aggregation in acute cerebral infarction
ChiCTR2000036340Phase 4Recruiting
- Sponsor
- Renji Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Ginkgo diterpene lactone meglumine in ischemic stroke and brain infarction (2 arms), sponsored by Renji Hospital. Primary endpoints: PL-12 MAR, VerifyNow ARU and 2 more. Started Oct 2020; status: recruiting.
02
Drugs
Ginkgo diterpene lactone meglumine
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on ChiCTR2000036340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036340.